Forefront Analytics LLC decreased its position in Mereo BioPharma Group plc (NASDAQ:MREO – Free Report) by 45.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,124 shares of the company’s stock after selling 29,525 shares during the quarter. Forefront […]
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,210,000 shares, a drop of 21.9% from the April 30th total of 2,830,000 shares. Based on an average trading volume of 1,010,000 […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 2,210,000 shares, a decrease of 21.9% from the April 30th total of 2,830,000 shares. Based on an average trading volume of 1,010,000 […]